← Back to guidelines
Cardiology62 papers

Fibrosing colonopathy

Last edited: 4/14/2026

Overview

Fibrosing colonopathy refers to severe, progressive fibrotic changes primarily affecting the colon, often associated with chronic inflammatory or immune-mediated conditions. While the provided abstracts focus more on fibrosing lung diseases and abdominal fibrosing conditions, the core concept involves excessive fibrosis leading to organ dysfunction 2.

Diagnosis

  • Imaging studies (CT, MRI) essential for identifying fibrotic changes and organ involvement 2.
  • Histopathologic analysis confirms proliferative fibrosis and chronic inflammation 2.
  • Unique imaging features may help differentiate conditions like sclerosing peritonitis 2.
  • Immunopathological etiology should be considered, especially in immune-mediated conditions 3.
  • Management

  • No specific drug classes or doses mentioned for fibrosing colonopathy directly.
  • Management often involves addressing underlying causes (e.g., immune-mediated conditions) 3.
  • Supportive care and symptomatic treatment may be necessary 3.
  • Special Populations

  • No specific details provided regarding pregnancy, pediatrics, elderly, or comorbidities related to fibrosing colonopathy 23.
  • Key Recommendations

  • Utilize imaging techniques (CT, MRI) for diagnosis and monitoring of fibrotic progression 2. (Evidence: Moderate)
  • Consider histopathologic evaluation to confirm the presence of proliferative fibrosis and chronic inflammation 2. (Evidence: Moderate)
  • Tailor management strategies to address underlying etiologies, particularly immune-mediated causes 3. (Evidence: Weak)
  • References

    1 Sverzellati N, Odone A, Silva M, Polverosi R, Florio C, Cardinale L et al.. Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist. La Radiologia medica 2018. link 2 George V, Tammisetti VS, Surabhi VR, Shanbhogue AK. Chronic fibrosing conditions in abdominal imaging. Radiographics : a review publication of the Radiological Society of North America, Inc 2013. link 3 Sobrinho-Simões MA, Vaz Saleiro J, Wagenvoort CA. Mediastinal and hilar fibrosis. Histopathology 1981. link 4 Katzenstein AL, Mazur MT. Pulmonary infarct: an unusual manifestation of fibrosing mediastinitis. Chest 1980. link

    Original source

    1. [1]
      Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist.Sverzellati N, Odone A, Silva M, Polverosi R, Florio C, Cardinale L et al. La Radiologia medica (2018)
    2. [2]
      Chronic fibrosing conditions in abdominal imaging.George V, Tammisetti VS, Surabhi VR, Shanbhogue AK Radiographics : a review publication of the Radiological Society of North America, Inc (2013)
    3. [3]
      Mediastinal and hilar fibrosis.Sobrinho-Simões MA, Vaz Saleiro J, Wagenvoort CA Histopathology (1981)
    4. [4]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG